Androgen receptor in triple negative breast cancer: A potential target for the targetless subtypeLorenzo Gerratana, Grazia Arpino, Debora Basile et al.|Cancer Treatment Reviews|2018Cited by 282
CDK 4/6 Inhibitors as Single Agent in Advanced Solid TumorsFrancesco Schettini, Lucia Del Mastro, Irene De Santo et al.|Frontiers in Oncology|2018Cited by 205
Fractional microablative CO2 laser in breast cancer survivors affected by iatrogenic vulvovaginal atrophy after failure of nonestrogenic local treatments: a retrospective studyTiziana Pagano, Giuseppe De Placido, Pasquale De Rosa et al.|Menopause The Journal of The North American Menopause Society|2017Cited by 76
Strain-oriented strategy for guiding cardioprotection initiation of breast cancer patients experiencing cardiac dysfunctionCiro Santoro, Maurizio Galderisi, Roberta Esposito et al.|European Heart Journal - Cardiovascular Imaging|2019Cited by 61
Unexpected ovarian activity in premenopausal breast cancer survivors treated with exemestane and GnRH analoguesAlessandro Conforti, Carlo Alviggi, Francesco Schettini et al.|The Breast Journal|2019Cited by 7